Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-03

Clinical Trial Update: A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of CAN04 in combination with various chemotherapy regimens for advanced solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CAN04

Snippet

Sponsor: Cantargia AB | Conditions: Advanced Solid Tumors, Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED